MedTrace Logo

Erector Spinae Plane Block vs Erector Spinae Plane Block With Serratus Anterior Plane Block in Thoracic Surgery

NCT04349774 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2022-11-14

No results posted yet for this study

Summary

This pilot study will prospectively compare continuous Erector Spinae Plane block (ESP) versus combination of continuous Erector Spinae Plane block and single shot Serratus Anterior Plane block for post-operative pain management in subjects undergoing primary thoracic surgery.

Conditions

  • Pain, Postoperative

Interventions

DRUG

Control Group - ESP block with SAP block

None - Control Group

DRUG

Treatment Group - ESP block with SAP normal saline

Substitution of normal saline in place of 0.375% Bupivacaine in SAP block

Sponsors & Collaborators

  • Anna Uskova

    lead OTHER

Principal Investigators

  • Dmitriy Gromov, DO · University of Pittsburgh Medical Center

  • Anna Uskova, MD · University of Pittsburgh Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2023-06-01
Completion
2023-12-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04349774 on ClinicalTrials.gov